{"schema_version":"1","generated_at":"2026-11-07T12:02:28.003Z","data_as_of":null,"url":"https://www.findmykol.com/kol/bahir-chamseddin","json_url":"https://www.findmykol.com/kol/bahir-chamseddin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"bahir-chamseddin","name":"Bahir Chamseddin","credential":"MD","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"institution":"The University of Texas Southwestern Medical Center","institution_url":"https://www.findmykol.com/institution/ut-southwestern-medical-center","city":"Dallas","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1336776137","orcid":"0000-0002-5729-3532","openalex":"A5034679990"},"summary":"Bahir Chamseddin is a Dermatology physician affiliated with The University of Texas Southwestern Medical Center. OpenAlex indexes 25 publications with 635 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Dermatology"]},"scholarship":{"works_count":25,"cited_by_count":635,"h_index":11,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":22,"program_years":{"first":2021,"last":null},"rows_total":30,"shown":3,"withheld":27,"rows":[{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":620.44,"payment_count":30,"source_url":"https://openpaymentsdata.cms.gov/search?query=1336776137"},{"payer":"Galderma Laboratories, L.P.","program_year":2025,"amount_usd":493.3,"payment_count":16,"source_url":"https://openpaymentsdata.cms.gov/search?query=1336776137"},{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":458.58,"payment_count":15,"source_url":"https://openpaymentsdata.cms.gov/search?query=1336776137"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1336776137","source":"payments"},"prescribing":{"data_year":2023,"areas_total":4,"areas_shown":3,"areas":[{"area":"Anti-infectives","share_pct":33.8,"classes_total":1,"classes":[{"class":"Azole Antifungal","setting":"prescribed","share_pct":33.8,"drugs":[{"name":"Ketoconazole","share_pct":100}],"max_beneficiaries":null}]},{"area":"Sensory organs","share_pct":26.5,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":26.5,"drugs":[{"name":"Clobetasol Propionate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":20.6,"classes_total":1,"classes":[{"class":"Arteriolar Vasodilator","setting":"prescribed","share_pct":20.6,"drugs":[{"name":"Minoxidil","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":25,"shown":5,"withheld":20,"matched_by":"OpenAlex author record","recent":[{"title":"Metabolic profiles of cutaneous lupus have abnormalities in the nicotinamide adenine dinucleotide pathway","year":2025,"journal":"Lupus Science & Medicine","source_url":"https://doi.org/10.1136/lupus-2024-001401","status":"verified"},{"title":"Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1","year":2025,"journal":"JID Innovations","source_url":"https://doi.org/10.1016/j.xjidi.2025.100380","status":"verified"},{"title":"LB1132 Portable tools to quantify stiffness as an outcome measure for cutaneous neurofibroma in NF1","year":2025,"journal":"Journal of Investigative Dermatology","source_url":"https://doi.org/10.1016/j.jid.2025.06.1421","status":"verified"},{"title":"A plague passing over: Clinical features of the 2022 mpox outbreak in patients of color living with HIV","year":2023,"journal":"HIV Medicine","source_url":"https://doi.org/10.1111/hiv.13517","status":"verified"},{"title":"Author Correction: Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus","year":2022,"journal":"Nature Communications","source_url":"https://doi.org/10.1038/s41467-022-30659-z","status":"verified"}],"source":"works"},"similar":[{"name":"Robert Toto","slug":"robert-toto","institution":"The University of Texas Southwestern Medical Center","specialty":"Nephrology","url":"https://www.findmykol.com/kol/robert-toto","json_url":"https://www.findmykol.com/kol/robert-toto/profile.json"},{"name":"Abhimanyu Garg","slug":"abhimanyu-garg","institution":"The University of Texas Southwestern Medical Center","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/abhimanyu-garg","json_url":"https://www.findmykol.com/kol/abhimanyu-garg/profile.json"},{"name":"Graham Emslie","slug":"graham-emslie","institution":"The University of Texas Southwestern Medical Center","specialty":"Child & Adolescent Psychiatry","url":"https://www.findmykol.com/kol/graham-emslie","json_url":"https://www.findmykol.com/kol/graham-emslie/profile.json"},{"name":"Jing Chen","slug":"jing-chen","institution":"The University of Texas Southwestern Medical Center","specialty":"Nephrology","url":"https://www.findmykol.com/kol/jing-chen","json_url":"https://www.findmykol.com/kol/jing-chen/profile.json"},{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Jon Hanifin","slug":"jon-hanifin","institution":"Oregon Health & Science University (OHSU)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jon-hanifin","json_url":"https://www.findmykol.com/kol/jon-hanifin/profile.json"},{"name":"Heidi Kong","slug":"heidi-kong","institution":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/heidi-kong","json_url":"https://www.findmykol.com/kol/heidi-kong/profile.json"},{"name":"Joel Gelfand","slug":"joel-gelfand","institution":"University of Pennsylvania","specialty":"Dermatology","url":"https://www.findmykol.com/kol/joel-gelfand","json_url":"https://www.findmykol.com/kol/joel-gelfand/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":27,"publications":20}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}